Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1984-04-26
1985-07-16
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514224, 544 31, C07D51314, C07D41714, A61K 3154
Patent
active
045297258
ABSTRACT:
1-pyridine substituted quino-benzothiazine having the formula: ##STR1## wherein X is halogen or hydrogen; R.sub.2 is a substituent; and R.sub.1 is hydrogen or a carboxy protecting group.
REFERENCES:
patent: 2919271 (1959-12-01), Craig et al.
patent: 3052678 (1962-09-01), Ziegler et al.
patent: 3294790 (1966-12-01), Harfenist
patent: 3493567 (1970-02-01), Draper et al.
patent: 3525743 (1970-08-01), Wolf et al.
patent: 3962438 (1976-06-01), Berkoff et al.
patent: 4017622 (1977-04-01), Minami et al.
patent: 4292317 (1981-09-01), Pesson
patent: 4382892 (1983-05-01), Hayakawa et al.
patent: 4443447 (1984-04-01), Gerster et al.
Abstract of Japanese Patent Document 112,040, Jun. 1982.
Abstract of Japanese Patent Document 216,545, Dec. 1982.
Huang et al., Chemical Abstracts, vol. 71, entry 49875u, (1969).
Vishwakarma et al., Chem. Abstr., vol. 97, entry 182322q, entry 162163k, (1982).
Abbott Laboratories
Ford John M.
Weinstock Steven F.
LandOfFree
1-pyridine substituted quino-benzothiazine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-pyridine substituted quino-benzothiazine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-pyridine substituted quino-benzothiazine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1736480